SAN FRANCISCO, Nov. 5 – Applied Gene Technologies has entered a development, manufacturing, and marketing deal with Taiwanese biopharmaceutical company AsiaGen, the companies announced Monday.

Applied Gene Technologies, based in San Diego, will develop tuberculosis diagnostics using its Tessera Array Technology for AsiaGen, which received exclusive rights to manufacture and market the product in Asia.

Applied Gene Technologies will receive an upfront payment for the development work, according to the company. Details of the payment were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.